+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clinical Development"

Eftilagimod alpha (IMP321) Emerging Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Eftilagimod alpha (IMP321) Emerging Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Pridopidine Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Pridopidine Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Tezepelumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Tezepelumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
Omburtamab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Omburtamab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
From
Rusfertide Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Rusfertide Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Tirzepatide, Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Tirzepatide, Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
GIVINOSTAT Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

GIVINOSTAT Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EB05 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EB05 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
ION363, Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ION363, Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Tofersen Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Tofersen Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
EPI-589 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPI-589 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
CNM-Au8 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CNM-Au8 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
VRAYLAR, Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VRAYLAR, Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Lorecivivint Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lorecivivint Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
SAPHNELO Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAPHNELO Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Gazyva Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Gazyva Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
HALNEURON Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HALNEURON Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Clinical Development market is a key component of the Drug Discovery process. It involves the testing of new drugs and treatments on human subjects in order to assess their safety and efficacy. Clinical Development typically involves a series of phases, beginning with pre-clinical trials and progressing through to Phase I, II, and III clinical trials. The results of these trials are used to determine whether a drug should be approved for use by regulatory authorities. The Clinical Development market is highly competitive, with a range of companies offering services such as clinical trial design, data management, and regulatory consulting. These companies are often specialized in specific therapeutic areas, such as oncology, neurology, and cardiology. Examples of companies in the Clinical Development market include Parexel, ICON, and Syneos Health. Show Less Read more